Management and Treatment of Placenta Accreta Spectrum
The definitive treatment for placenta accreta spectrum is planned cesarean hysterectomy with the placenta left in situ, performed at 34 0/7 to 35 6/7 weeks gestation at a level III or IV maternal care facility with a multidisciplinary team, because attempting to remove the placenta causes catastrophic hemorrhage. 1
Delivery Timing
Deliver between 34 0/7 and 35 6/7 weeks of gestation for stable patients. 2, 1 This narrow window exists because:
- Waiting beyond 36 weeks results in approximately 50% of patients requiring emergent delivery for hemorrhage 2, 1
- Earlier delivery increases neonatal morbidity from prematurity 1
- Administer antenatal corticosteroids when delivery is planned before 37 weeks 1
Facility Requirements
Delivery must occur at a level III or IV maternal care facility with the following immediately available resources 2, 1:
- Maternal-fetal medicine subspecialists 1
- Experienced pelvic surgeons 1
- Urologists 1
- Interventional radiologists 1
- Obstetric anesthesiologists 1
- Critical care specialists 1
- Blood bank with massive transfusion protocols 3, 2, 1
- ICU capabilities 2, 1
This level of care is essential because placenta accreta spectrum is considered a high-risk condition with serious associated morbidities, including severe hemorrhage, increased maternal mortality, and frequent need for hysterectomy. 3
Preoperative Optimization
Maximize hemoglobin values before delivery using oral or intravenous iron supplementation 1. Additional preoperative steps include:
- Verify exact surgical suite location and capabilities 1
- Confirm all necessary consultations have occurred 1
- Notify the blood bank in advance of scheduled delivery 1
- Consider ureteric stent placement if bladder involvement is suspected 1
Surgical Technique
The standard approach is cesarean hysterectomy with the placenta left in place rather than attempting placental delivery, which causes catastrophic hemorrhage. 3, 2, 1, 4 The surgical steps are:
- Make the uterine incision away from the placenta when possible 1
- Deliver the fetus 1
- Leave the placenta in situ—do not attempt removal 1, 4
- Proceed immediately to hysterectomy 1
Critical Intraoperative Management
Activate massive transfusion protocol early without waiting for laboratory confirmation if significant bleeding is present 1. Additional intraoperative measures include:
- Maintain patient temperature >36°C, as clotting factors function poorly at lower temperatures 1
- Consider tranexamic acid to reduce blood loss 1
- Re-dose prophylactic antibiotics if blood loss exceeds 1,500 mL 1
- Monitor baseline coagulation studies 1
Management of Unexpected Diagnosis at Delivery
If placenta accreta spectrum is encountered unexpectedly without prior diagnosis, immediately pause the case. 1 Then:
- Alert anesthesia 1
- Mobilize optimal surgical expertise 1
- Transfer the patient to a facility capable of performing cesarean hysterectomy if necessary 1
- Never attempt manual placental removal 1
This scenario represents a critical pitfall, as placenta accreta spectrum is underdiagnosed and can result in massive hemorrhage, disseminated intravascular coagulation, surgical injury, multisystem organ failure, and death. 5
Postoperative Care
Transfer to ICU for intensive hemodynamic monitoring. 1 Specific monitoring includes:
- Maintain vigilance for ongoing bleeding with a low threshold for reoperation 1
- Monitor for complications including ongoing bleeding, fluid overload, renal failure, and liver failure 1
- Watch for Sheehan syndrome (postpartum pituitary necrosis) in cases with significant hypoperfusion 1
Conservative (Uterine-Sparing) Management
Conservative management should be considered investigational and only attempted in carefully selected cases after detailed counseling about uncertain benefits and significant risks. 1 This approach carries a 28.6% recurrence risk in subsequent pregnancies. 1
Critical Pitfalls to Avoid
Never perform the following actions 1:
- Never attempt manual placental removal 1
- Never perform digital pelvic examination until placenta previa is excluded 1
- Never delay delivery beyond 36 weeks in stable patients 1
- Never deliver at a facility lacking massive transfusion capabilities 1
Risk Factor Context
Understanding risk factors helps identify patients requiring this intensive management approach. The most significant risk is placenta previa with prior cesarean deliveries, present in 49% of placenta accreta spectrum cases. 2 The risk increases dramatically from 3% with placenta previa alone to 11%, 40%, 61%, and 67% for the first, second, third, fourth, and fifth or more cesarean deliveries, respectively. 3 This combination creates abnormal placental location overlying a uterine scar where abnormal invasion is most likely to occur. 2